JNL · Class II · 21 CFR 866.5870

FDA Product Code JNL: Immunochemical, Thyroglobulin Autoantibody

Leading manufacturers include Beckman Coulter, Inc. and Siemens Healthcare Diagnostics, Inc..

22
Total
22
Cleared
111d
Avg days
1990
Since
Growing category - 2 submissions in the last 2 years vs 0 in the prior period
Review times increasing: avg 172d recently vs 105d historically

FDA 510(k) Cleared Immunochemical, Thyroglobulin Autoantibody Devices (Product Code JNL)

22 devices
1–22 of 22

About Product Code JNL - Regulatory Context

510(k) Submission Activity

22 total 510(k) submissions under product code JNL since 1990, with 22 receiving FDA clearance (average review time: 111 days).

Submission volume has increased in recent years - 2 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under JNL have taken an average of 172 days to reach a decision - up from 105 days historically. Manufacturers should account for longer review timelines in current project planning.

JNL devices are reviewed by the Immunology panel. Browse all Immunology devices →